HealthDay News - Improved sensitivity and diagnosis compared with enterography for patients without stenosis
HealthDay News - For patients without endoscopic or clinical suspicion of stenosis, capsule endoscopy (CE) demonstrates improved sensitivity for detection of Crohn's disease (CD) in the terminal ileum and superior diagnosis in the proximal small bowel, according to a study published in the February issue of Clinical Gastroenterology and Hepatology.
Michael Dam Jensen, M.D., from Lillebaelt Hospital Vejle in Denmark, and colleagues examined data from 93 patients with inflammatory bowel disease who were scheduled to undergo ileocolonoscopy, magnetic resonance enterography (MRE), and computed tomography enterography (CTE). If stenosis was excluded, patients also underwent CE. Physicians performing the procedures were unaware of patient histories or findings from other examinations.
The investigators identified 21 patients with CD in the terminal ileum. For diagnosis of CD in the terminal ileum, CE had sensitivity and specificity of 100 and 91 percent, MRE had 81 and 86 percent, and CTE had 76 and 85 percent, respectively. Proximal CD was detected in 18 patients using CE, compared with two patients using MRE and six patients using CTE. Small bowel stenosis was seen in five patients using CTE and one patient using MRE. Cross-sectional imaging indicated additional stenosis in two of the patients who underwent complete ileocolonoscopies.
"In patients with suspected or newly diagnosed CD without endoscopic or clinical suspicion of stenosis, CE could be the new gold standard and first-line modality for detection of small bowel CD beyond the reach of the colonoscope," the authors write.
Copyright © 2011 HealthDay. All rights reserved.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.